4//SEC Filing
CARDIOVASCULAR SYSTEMS INC 4
Accession 0000914190-09-000170
CIK 0001222929operating
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 2:17 PM ET
Size
22.0 KB
Accession
0000914190-09-000170
Insider Transaction Report
Form 4
NELSON GLEN D
Director
Transactions
- Other
Warrant
2009-02-25+87,416→ 87,416 total(indirect: By LLC)Exercise: $5.71From: 2009-02-25Exp: 2014-02-24→ Common Stock (87,416 underlying)
Holdings
- 151,167(indirect: By LLC)
Common Stock
- 60,000
Common Stock
- 10,000
Stock Option (right to buy)
Exercise: $6.00From: 2004-12-01Exp: 2009-11-30→ Common Stock (10,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $8.00From: 2005-12-01Exp: 2010-11-30→ Common Stock (15,000 underlying) - 20,000
Stock Option (right to buy)
Exercise: $5.71From: 2006-12-19Exp: 2016-12-18→ Common Stock (20,000 underlying) - 6,681
Stock Option (right to buy)
Exercise: $5.11From: 2007-10-09Exp: 2017-10-08→ Common Stock (6,681 underlying) - 23,319
Stock Option (right to buy)
Exercise: $7.36From: 2007-11-13Exp: 2017-11-12→ Common Stock (23,319 underlying) - 132,042(indirect: By LLC)
Series A Conv Preferred Stock
→ Common Stock (132,042 underlying) - 43,235(indirect: By LLC)
Series A-1 Conv Preferred Stock
→ Common Stock (43,235 underlying) - 54,585(indirect: By LLC)
Series B Conv Preferred Stock
→ Common Stock (54,585 underlying) - 18,750(indirect: By LLC)
Warrant
Exercise: $5.71From: 2006-07-19Exp: 2011-07-19→ Series A Conv Preferred Stock (18,750 underlying) - 83,333(indirect: By LLC)
Warrant
Exercise: $6.00From: 2008-09-12Exp: 2013-09-12→ Common Stock (83,333 underlying)
Footnotes (5)
- [F1]Shares are held by GDN Holdings, LLC, of which Dr. Nelson is the sole owner.
- [F2]Each share of Series A convertible preferred stock is convertible at any time, at the holder's election, into 1.01 shares of common stock and has no expiration date.
- [F3]Each share of Series A-1 convertible preferred stock is convertible at any time, at the holder's election, into 1.03 shares of common stock and has no expiration date.
- [F4]Each share of Series B convertible preferred stock is convertible at any time, at the holder's election, into 1.01 shares of common stock and has no expiration date.
- [F5]Holders of approximately 68% of the outstanding preferred stock entered into an agreement with the Company whereby effective immediately prior to the effective time of the merger of the Company with Replidyne, Inc., all preferred stock will convert into shares of common stock. The warrants were issued pro rata to each preferred shareholder, based on the percentage of preferred stock held, in consideration for entering into such conversion agreement.
Documents
Issuer
CARDIOVASCULAR SYSTEMS INC
CIK 0001222929
Entity typeoperating
IncorporatedMN
Related Parties
1- filerCIK 0001222929
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 2:17 PM ET
- Size
- 22.0 KB